Potassium levels exceeding 8.5 mEq/L can cause respiratory paralysis or cardiac arrest and can suddenly be fatal.
Since hyperkalemia is known to be silent and quite often without symptoms, it can suddenly pose a serious complication, which can cause sudden death.
The most common cause of hyperkalemia is kidney disease. You will, therefore, very often find hyperkalemia associated with advanced kidney disease or kidney failure. What with other dangerous health consequences associated with high potassium levels, the medical fraternity takes this condition very seriously. When a patient of hyperkalemia is admitted in the hospital, he is almost always admitted to the
What with other dangerous health consequences associated with high potassium levels, the medical fraternity takes this condition very seriously. When a patient of hyperkalemia is admitted in the hospital, he is almost always admitted to the
When a patient of hyperkalemia is admitted to the hospital, he is almost always admitted to the stroke unit or the ICU for fear of sudden death.
Hemodialysis with comorbidities
Electrolyte imbalance can lead to arrhythmias and sudden death. This can happen more in hyperkalemic patients on hemodialysis and end-stage renal disease.
This especially happens when there are co-existing diseases such as congestive heart failure, coronary artery disease, and diabetes.
ACE inhibitors and ARBs
In addition, anti-hypertension drugs such as angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs), which increase serum potassium substantially, can significantly contribute to increasing the risk of sudden death.
In older patients on angiotensin converting enzyme inhibitors (ACE inhibitors) or angiotensin receptor blockers (ARBs), co-trimoxazole (e.g. Bactrim) is associated with an increased risk of sudden death.
It is believed that undiagnosed severe hyperkalemia may be the cause of this finding. Co-trimoxazole induced hyperkalemia is quite common, can set in suddenly, and can be life-threatening.
Studies reveal that the use of co-trimoxazole with ACE inhibitors and ARBs results in an almost sevenfold increase in the risk of hyperkalemia related hospital admission when compared to other antibiotics such as amoxicillin.
This drug interaction can cause life threatening hyperkalemia,
It is necessary, therefore, that in the elderly who are on ACE inhibitors and ARBs, careful thought should be given to the choice of antibiotics.
Congestive cardiac failure (CCF) and hyperkalemia
The symptoms of hyperkalemia often mimic those of advanced CHF, lower-extremity weakness being one such symptom.
Hyperkalaemic cardiotoxicity in a CCF patient gives rise to arrhythmias, which poses a serious risk of cardiac arrest and sudden death.